AQR Capital Management
TBIO

AQR Capital Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

AQR Capital Management’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-54,424
Closed -$1.5M – 2378
2021
Q2 		$1.5M Sell
54,424
-55,857
-51% -$1.1M ﹤0.01% 1378
2021
Q1 		$1.82M Buy
110,281
+44,147
+67% +$1.01M ﹤0.01% 1253
2020
Q4 		$1.22M Buy
66,134
+19,250
+41% +$345K ﹤0.01% 1410
2020
Q3 		$638K Buy
46,884
+35,695
+319% +$550K ﹤0.01% 1630
2020
Q2 		$201K Buy
+11,189
New +$169K ﹤0.01% 1995

AQR Capital Management's TBIO Position: Q3 2021 in Review

AQR Capital Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 54,424 shares — an estimated $1.5M sold.

AQR Capital Management first reported a position in TBIO in Q2 2020 and held it in 5 quarters. The position peaked at $1.82M in Q1 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • AQR Capital Management reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • AQR Capital Management sold 54,424 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $1.5M.
  • AQR Capital Management first reported a position in Translate Bio, Inc. Common Stock in Q2 2020 and held it in 5 quarters.
  • AQR Capital Management's Translate Bio, Inc. Common Stock position peaked at $1.82M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on AQR Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.